Cabinet likely to consider Rs 12K cr capital infusion in PSBs

Tags: News
Government is likely to consider next week the proposal to infuse Rs 12,000 crore into public sector banks, a senior official of the Finance Ministry said.

The ministry has approved investment of Rs 12,000 crore in 12 public sector banks including State Bank of India, Central Bank of India and United Bank of India.

The fund would be disbursed before March to these public sector banks. Country's largest lender SBI will get Rs 3,004 crore as part of recapitalisation plan to boost the bank's capital base.

Government has been infusing funds in the public sector banks in the last couple of years to strengthen their finances.

It has injected about Rs 32,000 crore so far in the previous two financial years.

During 2011-12, public sector banks got Rs 12,000 crore for improving their capital adequacy ratio.

The government pumped in Rs 20,157 crore in public sector banks in 2010-11 to maintain tier I capital at 8 per cent and increase

government’s equity in some banks to 58 per cent.

Besides, the Finance Ministry will also seek Cabinet approval for fund infusion in the public sector banks till March 2018.

The Finance Ministry has made assessment of the capital needs of public sector banks for meeting Basel III norms to be complied in a phased manner, ending March 2018.

As per the existing norms, capital infusion beyond Rs 300 crore in a company requires Cabinet approval.

In order to strengthen risk management mechanism, the Reserve Bank issued guideline for Basel III last year.

The implementation of the capital adequacy guidelines based on the Basel III capital regulations was to begin from January 1, 2013. However, RBI recently deferred it by another three months.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

FC NEWSLETTER

Stay informed on our latest news!

EDITORIAL OF THE DAY

  • Daiichi’s legal move against Ranbaxy’s ex-promoters will set precedence

    Daiichi Sankyo’s decision to take the former promoters of Ranbaxy to court is welcome move.

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Roopen Roy

Where is the Charging Bull headed to?

On a balmy spring morning last week, I was admiring ...

Rajgopal Nidamboor

The disdainful wrath of greed

It is rightly said that money isn’t the root of ...

Gautam Gupta

Immense potential of e-commerce in fashion and apparel

Michael Aldrich launched online shopping in1979 with no clue whatsoever ...